Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

What We’re Learning About Drug Company Payments to Doctors

Loeb & Loeb partner Scott Liebman is quoted on the impact of the federal government’s disclosure of payments made to doctors by pharmaceutical and medical device companies – information, which is being made public under a provision of the 2010 Affordable Care Act.
Click here to read the article on the New York Times’ website.